Lynch Frederick J 4
4 · H-CYTE, INC. · Filed Mar 23, 2022
Insider Transaction Report
Form 4
H-CYTE, INC.HCYT
Lynch Frederick J
10% Owner
Transactions
- Exercise of In-Money
COMMON STOCK
2022-03-21$0.01/sh+8,321,785$116,505→ 8,321,785 total(indirect: (SEE FOOTNOTE)) - Other
STOCK PURCHASE WARRANTS
2022-03-21$0.01/sh+8,321,785$116,505→ 8,321,785 total(indirect: (SEE FOOTNOTE))Exercise: $0.01From: 2022-03-21Exp: 2027-03-21→ COMMON STOCK (8,321,785 underlying) - Exercise of In-Money
STOCK PURCHASE WARRANTS
2022-03-21−8,321,785→ 17,886,434 total(indirect: (SEE FOOTNOTE))Exercise: $0.01From: 2020-09-24Exp: 2030-09-24→ COMMON STOCK (8,321,785 underlying)
Footnotes (3)
- [F1]Securities held of record by CFRS Investments, LLC, of which Frederick J. Lynch is the sole manager. Each reporting person disclaims beneficial ownership of the securities except to the extent of its or his pecuniary interest therein.
- [F2]Received in connection with variable conversion price notes. No additional consideration was paid for warrants. Exercise price became fixed at closing of Qualified Financing.
- [F3]Represents five-year inducement warrants received from the issuer in connection with the exercise of the ten-year warrants.